The Discounted Cash Flow (DCF) valuation of Regenxbio Inc (RGNX) is (143.14) USD. With the latest stock price at 8.16 USD, the upside of Regenxbio Inc based on DCF is -1854.2%.
Based on the latest price of 8.16 USD and our DCF valuation, Regenxbio Inc (RGNX) is a sell. selling RGNX stocks now will result in a potential gain of 1854.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 8.4% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (423.18) - (88.04) | (143.14) |
| Upside | -5286.0% - -1179.0% | -1854.2% |